Inventor

CHANDRARATNA ROSHANTHA A

US232 patents

⚠️ This page may combine multiple inventors who share the name “CHANDRARATNA ROSHANTHA A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

CHANDRARATNA ROSHANTHA A

ALLERGAN INC

Method of identifying negative hormone and/or antagonist activities

2,4-pentadienoic acid derivatives having retinoid-like biological activity

N-aryl substituted tetrahydroquinolines having retinoid agonist, retinoid antagonist or retinoid inverse agonist type biological activity

Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity

[4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity

Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity

2,4-pentadienoic acid derivatives having retinoid-like biological activity

Substituted heteroarylamides having retinoid-like biological activity

Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity

Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities

Methods of treatment with compounds having RARα receptor specific or selective activity

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Aryl or heteroaryl substituted 3,4-dihydroanthracene and aryl or heteroaryl substituted benzo [1,2-g]chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivatives having retinoid antagonist or retinoid inverse agonist type biological activity

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Male anti-fertility agents

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists

Aryl or heteroaryl amides of tetrahydronaphthalene, chroman, thiochroman and 1,2,3,4-tetrahydroquinoline carboxylic acids, having an electron withdrawing substituent in the aromatic or heteroaromatic moiety, having retinoid-like biological activity

2,4-pentadienoic acid derivatives having retinoid-like biological activity

2,4-Pentadienoic acid derivatives having retinoid-like biological activity

Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

Tetrahydronaphthalene derivatives substituted in the 8 position with alkyhidene groups having retinoid and/or retinoid antagonist-like biological activity

Benzo 1,2-g!-chrom-3-ene and benzo 1,2-g!-thiochrom-3-ene derivatives

Oxime substituted tetrahydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity

ALLERGAN SALES INC

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological activity

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI

Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity

Trisubstituted phenyl derivatives having retinoid agonist or inverse agonist type biological activity

Methods of identifying compounds having nuclear receptor negative hormone and/or antagonist activities

2,4-pentadienoic acid derivatives having selective activity for retinoid X (RXR) receptors

2,4-pentadienoic acid derivatives having retinoid-like biological activity

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Benzo[1,2-G]-chrom-3-ene, and benzo[1,2-G]-thiochrom-3-ene derivatives

Tetrahdroquinolin-2-one 6 or 7-yl, tetrahdroquinilin-2-thione 6 or 7-yl pentadienoic acid and related derivatives having retinoid-like biological activity

Trisubstituted phenyl derivatives having retinoid agonist, antagonist or inverse agonist type biological activity

2,4-pentadienoic acid derivatives having retinoid-like biological activity

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity

Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities

2,4-pentadienoic acid derivatives having retinoid-like biological activity

IO THERAPEUTICS INC

Treatment of cancer with specific RXR agonists

Treatment of cancer with specific RXR agonists

Treatment of cancer with specific RXR agonists

Treatment of cancer with specific RXR agonists

CHANDRARATNA ROSHANTHA A

Treatment of cancer with specific RXR agonists

Treatment of cancer with specific RXR agonists

(unassigned)

Substituted diaryl or diheteroaryl methanes, ethers and amines having retinoid agonist, antagonist or inverse agonist type biological

UNIV JOHNS HOPKINS MED

Method of preventing proliferation of retinal pigment epithelium by retinoic acid receptor agonists